Consun Pharmaceutical Group Limited (HKG:1681)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
17.39
+0.89 (5.39%)
At close: Mar 27, 2026

HKG:1681 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2342,9082,7482,4502,196
Short-Term Investments
2,669958834.94589.17230
Cash & Short-Term Investments
3,9033,8663,5833,0392,426
Cash Growth
0.98%7.88%17.89%25.26%25.05%
Accounts Receivable
354.54297.57255.84259.56351.23
Other Receivables
-72.5554.1336.118.34
Receivables
354.54370.12309.97295.66369.57
Inventory
271.41315.51384.91287.66257.62
Restricted Cash
42.9---2.32
Other Current Assets
32.42----
Total Current Assets
4,6054,5514,2783,6233,056
Property, Plant & Equipment
921.17925.54863.71875858.45
Long-Term Investments
513.8329.089.236.5-
Other Intangible Assets
265.61268.96283.14311.9341.66
Long-Term Deferred Tax Assets
41.9512.5217.8436.4346.86
Other Long-Term Assets
62.7165.6755.9939.8759.94
Total Assets
6,4105,8535,5084,8924,363
Accounts Payable
1,18875.6483.159.8966.64
Accrued Expenses
-736.12638.76566.13465.53
Current Portion of Long-Term Debt
200253.34503.42450.52599.3
Current Portion of Leases
9.716.424.223.713.12
Current Income Taxes Payable
31.5147.6343.3832.892.54
Current Unearned Revenue
1.3460.8217.5639.9821.21
Other Current Liabilities
-190.83204.57197.37199.07
Total Current Liabilities
1,4301,3711,4951,3501,357
Long-Term Leases
3.217.413.95.958.55
Long-Term Unearned Revenue
12.914.6419.1818.9316.7
Long-Term Deferred Tax Liabilities
125.7267.1971.2178.0169.3
Total Liabilities
1,5721,4601,5891,4531,452
Common Stock
67.2367.3163.8163.4564.8
Additional Paid-In Capital
-216.4618.15-19.79
Retained Earnings
-3,6503,3812,9132,393
Treasury Stock
---83.17-83.17-113.32
Comprehensive Income & Other
4,468163.67247.15251.7253.89
Total Common Equity
4,5354,0983,6273,1452,618
Minority Interest
302.84295.45292.21293.87293.08
Shareholders' Equity
4,8384,3933,9193,4392,911
Total Liabilities & Equity
6,4105,8535,5084,8924,363
Total Debt
212.92267.17511.53460.18610.97
Net Cash (Debt)
3,6913,5993,0722,5791,815
Net Cash Growth
2.56%17.15%19.10%42.08%30.52%
Net Cash Per Share
4.314.323.843.262.26
Filing Date Shares Outstanding
847.34830.83792.43788.39805.64
Total Common Shares Outstanding
847.34830.83792.43788.39805.64
Working Capital
3,1743,1812,7832,2721,698
Book Value Per Share
5.354.934.583.993.25
Tangible Book Value
4,2693,8293,3432,8332,276
Tangible Book Value Per Share
5.044.614.223.592.83
Buildings
-399.2338.28334.82334.1
Machinery
-363.52324.86302.16282.15
Construction In Progress
-412.24416.43416.01381.67
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.